PL
PL · PL · PL-100315522
DuoResp Spiromax
ATC R03AK07
Last synced from URPL (Poland) on
Identification
ManufacturerTeva Pharma B.V.
CountryPL (PL)
ATC codeR03AK07
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 3
- gtin05909991136932
- gtin05909991136949
- gtin05909991136956
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do inhalacji",
"source": "urpl",
"strength": "(160 mcg + 4,5 mcg)/dawkę inh.",
"packaging": "05909991136932 ¦ Rp ¦ EU/1/14/920/001 ¦ 91240\n1 inhalator 120 dawek\n05909991136949 ¦ Rp ¦ EU/1/14/920/002 ¦ 91241\n2 inhalatory 120 dawek\n05909991136956 ¦ Rp ¦ EU/1/14/920/003 ¦ 91242\n3 inhalatory 120 dawek",
"substance": "Budesonidum 160 mcg + Formoteroli fumaras 4.5 mcg",
"common_name": "Budesonidum + Formoteroli fumaras dihydricus",
"pl_product_id": "100315522",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code R03AK07.
Access this data programmatically
Query DuoResp Spiromax and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.